Global 3D Cell Culture Market 2022-2028

Global 3D Cell Culture Market 2022-2028

Global 3D cell culture market was valued at $1.3 billion in 2021 and is growing at a CAGR of 14.8% during the forecast period. Rising demand for organ transplantation is one of the prime factors affecting and driving the market. Cost effective along with time saving culture technique, broad range of application among others is also estimated to be the prime factors that are contributing significantly towards the growth of the market. However, unclear regulation in some countries along with high cost involvement in tissue engineering are some major factors constraints which are hindering the growth of the global 3D cell culture market across the globe.

However, increasing funding from the government along with private investors is one of the key factors that are creating opportunity in the market. New launches in the market are likely to drive the growth of the global 3D cell culture market. For instance, in April 2021, Biogelx had recently put forward scientific reports in which it had highlighted about Peptide based scaffolds that has a focal point with the proper usage of peptide that is based hydrogels as scaffolds for primary liver cells as 3D cell culture. Around 600 million people suffer from liver disease across the globe and this hydrogel offering would be useful in these regards.

Impact of COVID-19 on the Global 3D Cell Culture Market

The global 3D cell culture market is hardly hit by the COVID-19 pandemic since December 2019. The COVID-19 pandemic in the major economies has disrupted the manufacturing and transportation activities. However, for key market player, scaffold-based and scaffold-free techniques can be supportive in developing novel therapeutics against COVID-19.

Segmental Outlook

The market is segmented based on product, application and end user. Based on product, the market is segmented into scaffold-based 3d cell culture, scaffold-free 3d cell culture and other. By application, the market is segmented into cancer and stem cell research, drug discovery, toxicology and tissue engineering & regenerative medicine. By end user, market is segmented into pharmaceutical & biotechnology companies, research institutes and other.

Based on the end-user, pharmaceutical & biotechnology companies hold a significant share in the market segment as they are mostly involved in 3d cell culture in this segment for providing better offering. Some of the factors that are driving the market in this segment are presence of companies in big numbers, increasing companies spending towards R&D along with technology that are developed for application in order to discover drug.

Regional Outlooks

The global 3D cell culture market is analyzed based on the geographical regions that are contributing significantly towards the growth of the market. Based on the geography, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America held a considerable share in 2020 in the global 3D cell culture market. Some factors that are boosting the market growth in North America are high expenditure in healthcare along with investment in R&D. Additionally, increasing number of cases due to cancer in the region and presence of universities and research organization that are involved in various cell based approaches are some of the other factor that are driving the growth of the market in this region.

Asia-Pacific will have Considerable Growth in the Global 3D Cell Culture Market

Asia-Pacific region is expected to witness significant growth opportunities for the market. Increasing prevalence of various types of cancer in emerging economies of the region are likely to drive the growth of the regional market. Further due to increasing demand for the R&D projects in India, China and South Korea are also some of the factors that are affecting and impacting the growth in this market.

Market Player Outlook

Key players of the global 3D cell culture market are Biogelx., Corning Inc., Lonza, Merck KgaA, Thermo Fisher Scientific Inc. among others. To survive in the market, these players adopt different marketing strategies such as product launches and collaboration. For instance, in June 2020, KIYATEC, Inc. had set forth the data for its ex vivo tumor 3d cell culture model in response to solid tumors. This data was being presented by the company in annual meeting of American association for cancer research as through this unmet need and requirement would be fulfilled in both preclinical drug development and clinical decision making in oncology.

In October 2019, Corning Inc. had brought two of its products offering in their portfolio of 3d cell culture. One of them is elplasia having the technology that is microcavity that supports analysis, formation along with culture of high-volume spheroid as it is a 3d cell culture microplate. Additionally, the other one is matrigel which is the matrix that supports organoid growth and differentiation. Moreover, this would lead to fulfill the demand in the industry related to spheroids in high densities.

In May 2018, Nano 3D Biosciences, Inc. was being acquired by Greiner Bio-One International GmbH. According to the company this strategic acquisition was done in order to bring enhancing technology in 3d cell culture to provide best products across the globe through research assess.